Sort   by:  
 Page size 
Linking clinical multi-omics analyses with mechanistic studies may improve the understanding of rare cancers. We leveraged two precision oncology programs to investigate rhabdomyosarcoma with FUS/EWSR1-TFCP2 fusions, an orphan malignancy without effective therapies. All tumors exhibited outlier ALK ...
ORGANISM(S): Homo sapiens (Human) 
2023-11-13 | PXD045522 | Pride
Intra-tumor heterogeneity of tumor-initiating cell (TIC) activity drives colorectal cancer (CRC) progression and therapy resistance. Here, we used single-cell mRNA-sequencing (scRNA-seq) of patient-derived CRC models to decipher distinct cell subpopulations based on their transcriptional profiles. C...
ORGANISM(S): Homo sapiens (Human) 
2021-05-07 | PXD018230 | Pride
Sort   by:  
 Page size